Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.91%86.46B | 12.99%94.92B | 3.51%23.21B | 22.41%25.35B | 9.66%23.86B | 17.70%22.5B | -5.79%84B | -8.06%22.43B | -5.70%20.71B | -4.11%21.75B |
| Cost of revenue | -8.76%73.73B | 13.38%80.81B | -1.20%19.25B | 23.03%21.4B | 13.34%20.37B | 20.49%19.8B | -6.45%71.28B | -7.78%19.49B | -4.85%17.39B | -8.01%17.97B |
| Gross profit | -9.75%12.73B | 10.83%14.1B | 34.76%3.96B | 19.23%3.95B | -7.87%3.49B | 0.63%2.7B | -1.89%12.73B | -9.82%2.94B | -10.00%3.31B | 20.12%3.79B |
| Operating expense | 5.36%7.51B | 9.82%7.13B | 11.13%1.96B | 7.57%1.73B | 7.41%1.68B | 13.08%1.76B | 5.77%6.49B | 2.09%1.76B | 5.71%1.61B | 7.34%1.57B |
| Operating profit | -25.18%5.22B | 11.88%6.98B | 70.06%2.01B | 30.26%2.22B | -18.65%1.81B | -16.39%949M | -8.76%6.24B | -23.19%1.18B | -21.09%1.7B | 31.13%2.22B |
| Net non-operating interest income (expenses) | -437.50%-81M | 117.39%24M | 42.50%-23M | 0.00%-32M | 250.00%45M | 194.44%34M | -0.73%-138M | -33.33%-40M | 13.51%-32M | -15.38%-30M |
| Non-operating interest income | -58.39%67M | 666.67%161M | 26.67%19M | 450.00%11M | 2,533.33%79M | 5,100.00%52M | 50.00%21M | 650.00%15M | 100.00%2M | -70.00%3M |
| Non-operating interest expense | 8.03%148M | -13.84%137M | -23.64%42M | 26.47%43M | 3.03%34M | -51.35%18M | 5.30%159M | 71.88%55M | -10.53%34M | -8.33%33M |
| Net investment income | -83.69%128M | 57.31%785M | 21.69%202M | 25.32%-118M | -88.15%16M | 92.42%685M | 256.43%499M | 764.00%166M | -319.44%-158M | 136.84%135M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 117.65%3M | -466.67%-17M | -13.33%-17M | 0.00%-1M | 0 | -92.31%1M | 90.63%-3M | 25.00%-15M | 66.67%-1M | 0 |
| Less:Other special charges | -140.00%-4M | 900.00%10M | ---- | ---- | --0 | 92.31%-1M | -91.67%1M | --13M | -66.67%1M | --0 |
| Less:Write off | -85.71%1M | 250.00%7M | ---- | ---- | ---- | ---- | -90.00%2M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 54.65%-39M | -68.63%-86M | -966.67%-26M | 100.00%4M | -33.33%-84M | 185.71%20M | 8.93%-51M | -57.14%3M | 100.00%2M | 4.55%-63M |
| Income before tax | -31.92%5.23B | 17.44%7.68B | 65.63%2.14B | 36.75%2.07B | -21.10%1.78B | 14.51%1.69B | -3.04%6.54B | -11.81%1.29B | -30.88%1.51B | 36.37%2.26B |
| Income tax | -41.88%1.46B | 154.57%2.51B | 180.91%661M | 36.96%693M | -28.23%595M | 19.31%556M | -48.16%984M | -489.05%-817M | -29.62%506M | 59.12%829M |
| Net income | -27.10%3.77B | -6.84%5.18B | -29.82%1.48B | 36.51%1.38B | -16.91%1.19B | 12.19%1.13B | 14.62%5.56B | 67.91%2.11B | -31.38%1.01B | 25.75%1.43B |
| Net income continuous operations | -27.10%3.77B | -6.84%5.18B | -29.87%1.48B | 36.64%1.38B | -16.97%1.19B | 12.29%1.13B | 14.62%5.56B | 68.05%2.11B | -31.50%1.01B | 25.95%1.43B |
| Noncontrolling interests | 0.00%84M | -26.32%84M | 0.00%15M | -58.33%10M | 34.78%31M | -46.15%28M | 2.70%114M | -51.61%15M | 14.29%24M | -41.03%23M |
| Net income attributable to the company | -27.53%3.69B | -6.43%5.09B | -30.09%1.46B | 39.06%1.37B | -17.81%1.16B | 15.38%1.1B | 14.91%5.44B | 70.94%2.09B | -32.11%983M | 28.32%1.41B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -27.53%3.69B | -6.43%5.09B | -30.09%1.46B | 39.06%1.37B | -17.81%1.16B | 15.38%1.1B | 14.91%5.44B | 70.94%2.09B | -32.11%983M | 28.32%1.41B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -27.37%289.96 | -6.45%399.25 | -30.06%114.82 | 38.93%107.1 | -17.85%90.77 | 15.35%86.56 | 14.89%426.78 | 70.79%164.16 | -32.12%77.09 | 28.37%110.49 |
| Diluted earnings per share | -27.37%289.96 | -6.45%399.25 | -30.09%114.766 | 39.86%107.1 | -17.30%90.77 | 15.35%86.56 | 14.89%426.78 | 70.89%164.16 | -32.56%76.575 | 27.52%109.7601 |
| Dividend per share | 5.00%126 | 20.00%120 | 20.00%120 | 0 | 0 | 0 | 25.00%100 | 25.00%100 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |